Abstract: Deubiquitinating enzymes (DUBs) catalyze the cleavage of ubiquitin from target proteins.U biquitin is posttranslationally attached to proteins and serves as an important regulatory signal for key cellular processes.Inthis study,novel activity-based probes to study DUBs were synthesized that comprise au biquitin moiety and an ovel disulfide warhead at the C-terminus.T hese reagents can bind DUBs covalently by forming ad isulfide bridge between the active-site cysteine residue and the ubiquitin-based probe.Asdisulfide bridges can be broken by the addition of ar educing agent, these novel ubiquitin reagents can be used to capture and subsequently release catalytically active DUBs,w hereas existing capturing agents bind irreversibly.T hese novel reagents allow for the study of these enzymes in their active state under various conditions.
The modification of target proteins with ubiquitin (Ub), ap rocess called ubiquitination, is ak ey post-translational event that regulates awide range of cellular processes.Ubis ahighly conserved 76 amino acid protein, which is conjugated to proteins by the formation of an isopeptide bond between the C-terminus of Ub and alysine residue or the N-terminus of at arget protein. Ub can also be coupled to other Ub moieties to form various polyubiquitin chains.Deubiquitinating enzymes (DUBs) catalyze the cleavage of these isopeptide bonds,t hereby regulating the ubiquitination of target proteins.T he human genome encodes about 80 active DUBs, which can be classified into five classes of cysteine( Cys) proteases and one class of metalloprotease DUBs. [1] As the function of many DUBs is still unknown, studying these enzymes in their active state,e ither in isolation or as part of aprotein complex, is of great importance.Existing reagents to study the activity of DUBs include cleavable Ub-containing substrates [2] and covalently binding activity-based probes (ABPs) [3] that react with the active-site Cys residue.T he latter have been used in activity profiling,inhibitor screening, and DUB identification.
[3b] However,t hese ABPs bind irreversibly to the active site of the DUB,r endering them inactive.I nt his study,w ed eveloped aU b-based ABP with an ovel warhead that captures DUBs from cell extracts and allows for their release in an active state (Scheme 1).
In our probe design, we intended to use reagents that can reversibly modify thiols as Ub-based ABPs react with the active-site Cys residue.M any such reagents,i fn ot all, are highly reactive,a nd thus unspecific towards Cys residues in proteins.T herefore,p revious methods to modify specific cysteines relied on the mutation of non-target cysteines to prevent their modification. Fore xample,G lcNAc-methylthiosulfonate has been used to modify proteins with GlcNAc moieties on specific cysteines. [4] In these proteins,undesirable Cys residues were replaced by serine residues.O ther known reagents used for the modification of Cys residues are disulfides (R'ÀSÀSÀR''), which are less reactive.T he Cys thiolate attacks the disulfide bond, and subsequently an ew asymmetric disulfide is formed in ap rocess named thiolspecific exchange.C hatterjee and co-workers have used this approach to generate aubiquitinated histone complex. [5] They modified aC ys residue that was introduced in histone 2B by first activating the thiol using 2,2'-dithiobis(5-nitropyridine) to form ad isulfide.S ubsequently,aUb moiety carrying a C-terminal aminoethanethiol group was coupled. We exploited the thiol-specific exchange for the design of areversible warhead for our novel DUB ABP.W epostulated that aU bm oiety would direct our disulfide ABP to the active-site cysteine in DUBs.T he glycine residue at position 76 of Ub was replaced with methyl disulfide as awarhead (Scheme 2). We hypothesized that this disulfide moiety would [3c , 7] TheN -terminus of Ub 1-75 (4)w as subsequently modified with aB oc group (5a), modified with aP EG spacer and ab iotin moiety (5b), or modified with N,N'-Boc-protected 5-carboxyrhodamine 110 [6, 8] (5c). Thep eptides were then cleaved from the resin using hexafluoroisopropanol (HFIP). 2-(Methyldisulfanyl)ethan-1-amine was coupled to the C-terminus of Ub 1-75 as the warhead (6 a-6c). 2-(Methyldisulfanyl)ethan-1-amine was synthesized as described previously. [9] TFA-mediated deprotection and purification yielded probes 1, 2,and 3 (Scheme 2 and Figure S1 a). Thep robes were analyzed by SDS-PAGE and LC-MS ( Figure S1 ).
To test whether our novel Ub-based DUB probes containing the disulfide warhead are able to bind to DUBs in vitro,weincubated the DUB UCHL3 with the probes Ub SS or biotin-PEG-Ub SS and followed the reactions by LC-MS and gel electrophoresis (Figures 1a,b and S2) . We observed an increase in the mass of UCHL3 corresponding to the binding of one probe moiety,w hich confirmed that these probes are indeed able to react covalently.A th igher concentrations of Ub SS and biotin-PEG-Ub SS ,a dditional bands were observed on the gel, which may represent binding of the probes to other Cys residues in UCHL3 although labeling is minimal as shown by LC-MS analysis.T od etermine whether the formed probe-DUB complex could be reduced, we incubated the reaction mixture with 10 mm dithiothreitol (DTT). As shown in Figures 1a,b 
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Communications ure 1c). Rho-Ub SS bound to all three DUBs as fluorescent bands with the expected molecular weights were observed after labeling.Inaddition, upwards shifts were observed after staining the gel with Coomassie Brilliant Blue,corresponding to the binding of one probe moiety to the DUBs.D TT treatment of the probe-DUB complex resulted in complete reduction and release of the reduced probe Rho-Ub SH from the DUB.
To determine whether the activity of aD UB could be restored after reduction, we first reacted UCHL3 with Ub SS and purified the complex by anion exchange chromatography (Figure 2a ). Unlabeled UCHL3 was purified using the same procedure (Figure 2b) . TheUb SS -UCHL3 complex was then either left as is or treated with DTT,after which the enzymatic activity was monitored using af luorogenic activity assay.I n this assay,Ub-Rhodamine110 (Ub-Rho110) is cleaved, which releases fluorescent Rho110. In the absence of DTT,n o cleavage was observed (Figure 2c) . However,u pon addition of DTT,U b-Rho110 was cleaved with similar kinetics as observed with unlabeled UCHL3, indicating that the disulfide bond in the Ub SS -UCHL3 complex was reduced, and the activity could be completely restored. Theactivity of UCHL3 was also monitored using the fluorescent Ub-propargylamide (PA) DUB ABP Rho-Ub-PA.
[3d] Fluorescent bands corresponding to UCHL3 bound to Rho-Ub-PAwere observed for both unlabeled UCHL3 and DTT-treated Ub SS -UCHL3 complexes,b ut not for untreated Ub SS -UCHL3 complexes (Figure 2d) . Correspondingly,u pward shifts in the silverstained gel were observed for both UCHL3 and DTT-treated Ub SS -UCHL3 complex. UCHL3 released from the Ub SS -UCHL3 complex after reduction showed similar labeling with Rho-Ub-PAa sU CHL3 alone,s uggesting that released UCHL3 regains full activity.
To validate that disulfide probes can also bind to DUBs in cell extract, we tested whether Ub SS can inhibit the binding of the fluorescent DUB ABP TMR-Ub-PA.
[3d] Cell extracts from HeLa cells were pre-incubated with 1 mm of Ub SS , followed by incubation with 1 mm of TMR-Ub-PA. As shown in Figure 3a ,Ub SS almost completely inhibited the labeling of DUBs by TMR-Ub-PA. Thep resence of DTT in the assay did allow for the labeling of DUBs with the TMR-Ub-PA probe,which suggests that Ub SS -DUB complexes are readily released or not formed in the presence of reducing agent. To visualize the binding of Ub SS to specific DUBs in cell extract, we overexpressed GFP fusions of the DUBs OTUB1 (Figures 3b and S4 a) , OTUB2 (Figure S4 b) , and USP8 ( Figure S4 c) . Cell extracts were made and incubated with Ub SS or Ub-PAa sapositive control. We visualized labeling by non-reducing SDS-PAGEfollowed by anti-GFP immuno- Figure 2 . Analytical LC-MS profile of a) Ub SS -UCHL3 complex and b) untreated UCHL3, purified by anion exchange chromatography. Additional peaks are detailed in Figure S3 . c) The enzymatic activity of untreateda nd DTT-treated purified Ub SS -UCHL3 complex and purified unlabeled UCHL3 was monitored using aUb-Rho110 fluorogenic DUB activity assay.d )The enzymatic activity of untreateda nd DTTtreated purified Ub SS -UCHL3 complex and purified unlabeled UCHL3 was monitored using the fluorescentDUB probe Rho-Ub-PA.
[3d]
Proteins were resolved by non-reducing SDS-PAGE and visualized by fluorescence scanning or silver staining. Ub* indicates reduced disulfide probe Ub SH (left panel) or Rho-Ub-PA and Ub SH (right panel). . Preincubation with N-methyl maleimide (NMM) was used as anegative control (lane 4). GFP-OTUB1 was visualized using anti-GFPimmunoblotting. Actin immunoblotting was used as aloading control. c) A HeLa cell extract was incubated with biotin-labeled Ub SS ,and reacted DUBs were captured on neutravidin resin. DUBs were released from the resin using DTT.Eluted DUBs and DUBs in the input cell extract were labeled with the fluorescently labeled ABP TMR-Ub-PA [3d] and visualized using in-gel fluorescence scanning.
www.angewandte.org blotting.Labeling with one Ub SS moiety was observed for all three GFP-fused DUBs,illustrated by ashift in migration on gel. Moreover,c atalytic cysteinem utants showed minimal labeling ( Figure S4 ), which corroborated that the active-site cysteine is the main site for modification.
To determine whether we can capture and release active DUBs from cell extract on resin, we incubated HeLa cell extracts with biotin-PEG-Ub SS .T he mixture was then allowed to bind to neutravidin resin. After washing of the resin, bound DUBs were eluted with the reducing agents DTT,TCEP, b-mercaptoethanol, or Cys (Figures 3c and S5) . TMR-Ub-PAwas added to the eluted fractions to visualize active DUBs by in-gel fluorescence scanning.The majority of DUBs that could be labeled in cell extract could also be labeled after elution with reducing agent. Notably,the 56 kDa DUB USP14 (65 kDa after binding of TMR-Ub-PA)
[3a,c,f, 10] was not retrieved or not active after elution. This is likely due to the absence of proteasome after washing the resin. USP14 is known to be activated upon association with the proteasome. [3a, 11] Almost no active DUBs were eluted when no reducing agents were used. Thus active DUBs can be caught using our biotin-PEG-Ub SS probe and specifically released under mild reducing conditions.
In conclusion, we have developed an ovel type of Ubbased activity-based probe containing am ethyl disulfide warhead that binds to DUBs by means of active-site-specific disulfide exchange.W eh ave shown that we can capture DUBs from cell extract on resin, and elute them by using reducing agents.The importance of this probe lies in its ability to isolate active DUBs from their natural environment as cellspecific post-translational modifications may be present that regulate DUB activity.Our reversible probe can thus be used to isolate active DUBs or DUB-protein complexes from cells to study the activity of specific DUBs in in vitro deubiquitination assays.T othe best of our knowledge,the DUB probes presented here are the first probes that can capture aspecific family of enzymes and release active enzymes under mild conditions.
